250 related articles for article (PubMed ID: 30596217)
21. Clinical Trials and Treatment of ATL.
Tsukasaki K; Tobinai K
Leuk Res Treatment; 2012; 2012():101754. PubMed ID: 23259064
[TBL] [Abstract][Full Text] [Related]
22. Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis.
Yonekura K; Kanzaki T; Gunshin K; Kawakami N; Takatsuka Y; Nakano N; Tokunaga M; Kubota A; Takeuchi S; Kanekura T; Utsunomiya A
J Dermatol; 2014 Mar; 41(3):239-44. PubMed ID: 24628073
[TBL] [Abstract][Full Text] [Related]
23. Biology and treatment of HTLV-1 associated T-cell lymphomas.
Tsukasaki K; Tobinai K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):3-14. PubMed ID: 23768636
[TBL] [Abstract][Full Text] [Related]
24. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
Hleihel R; Akkouche A; Skayneh H; Hermine O; Bazarbachi A; El Hajj H
Curr Oncol Rep; 2021 Nov; 23(12):141. PubMed ID: 34735653
[TBL] [Abstract][Full Text] [Related]
25. Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
Sakamoto H; Itonaga H; Sawayama Y; Furumoto T; Fujioka M; Chiwata M; Toriyama E; Kasai S; Nakashima J; Horai M; Kato T; Sato S; Ando K; Taguchi J; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Miyazaki Y
Hematol Oncol; 2020 Apr; 38(2):162-170. PubMed ID: 31922287
[TBL] [Abstract][Full Text] [Related]
26. Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.
Ishida T; Utsunomiya A; Jo T; Yamamoto K; Kato K; Yoshida S; Takemoto S; Suzushima H; Kobayashi Y; Imaizumi Y; Yoshimura K; Kawamura K; Takahashi T; Tobinai K; Ueda R
Cancer Sci; 2017 Oct; 108(10):2022-2029. PubMed ID: 28776876
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic options for adult T-cell leukemia/lymphoma.
Marçais A; Suarez F; Sibon D; Frenzel L; Hermine O; Bazarbachi A
Curr Oncol Rep; 2013 Oct; 15(5):457-64. PubMed ID: 23943384
[TBL] [Abstract][Full Text] [Related]
28. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research.
Tsukasaki K; Tobinai K
Clin Cancer Res; 2014 Oct; 20(20):5217-25. PubMed ID: 25320371
[TBL] [Abstract][Full Text] [Related]
29. Current management of adult T-cell leukemia/lymphoma.
Tobinai K
Oncology (Williston Park); 2009 Dec; 23(14):1250-6. PubMed ID: 20120837
[TBL] [Abstract][Full Text] [Related]
30. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
Fuji S; Shindo T
Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
[TBL] [Abstract][Full Text] [Related]
31. Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma.
Ureshino H; Kamachi K; Kimura S
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):326-331. PubMed ID: 30981611
[TBL] [Abstract][Full Text] [Related]
32. Mogamulizumab for the treatment of T-cell lymphoma.
Makita S; Tobinai K
Expert Opin Biol Ther; 2017 Sep; 17(9):1145-1153. PubMed ID: 28649848
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.
Satake A; Konishi A; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Ito T; Ishii K; Nomura S
Eur J Haematol; 2020 Dec; 105(6):704-711. PubMed ID: 32564395
[TBL] [Abstract][Full Text] [Related]
34. Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma.
Katsuya H
Int J Hematol; 2023 Apr; 117(4):512-522. PubMed ID: 36862273
[TBL] [Abstract][Full Text] [Related]
35. Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia.
Tanaka H; Fujiwara H; Ochi F; Tanimoto K; Casey N; Okamoto S; Mineno J; Kuzushima K; Shiku H; Sugiyama T; Barrett AJ; Yasukawa M
Clin Cancer Res; 2016 Sep; 22(17):4405-16. PubMed ID: 27091408
[TBL] [Abstract][Full Text] [Related]
36. Treatment of adult T-cell leukemia.
Uozumi K
J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
[TBL] [Abstract][Full Text] [Related]
37. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma.
Tsukasaki K; Marçais A; Nasr R; Kato K; Fukuda T; Hermine O; Bazarbachi A
Front Microbiol; 2020; 11():1207. PubMed ID: 32636814
[TBL] [Abstract][Full Text] [Related]
39. Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area.
Nakamura D; Yoshimitsu M; Tabuchi T; Arima N; Hayashida M; Inoue H; Matsushita K; Matsumoto T; Arima N; Ishitsuka K
Int J Hematol; 2020 Feb; 111(2):234-240. PubMed ID: 31721034
[TBL] [Abstract][Full Text] [Related]
40. [Role of anti-CCR4 antibody in the treatment of transplant-eligible patients with aggressive adult T-cell leukemia/lymphoma].
Fuji S
Rinsho Ketsueki; 2018; 59(4):426-431. PubMed ID: 29743403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
